Neurofibromatosis Type 1 (NF1)

Explore clinical trials studying Neurofibromatosis Type 1 (NF1). Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Neurofibromatosis Type 1 (NF1) trial results

Recruiting

NCT06961565

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +20 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Royal North Shore Hospital St Leonards, New South Wales, Australia

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

Asan Medical Center Seoul, South Korea

Completed

NCT07327164

Conditions: Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +38 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

Active, Not Recruiting

NCT03962543

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations: University of Alabama at Birmingham/Children's of Alabama Birmingham, Alabama, United States

Mayo Clinic Arizona Phoenix, Arizona, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

Children's Hospital Los Angeles Los Angeles, California, United States

View all 43 locations